Meeting the challenge of HIV diversity: Strategies to mitigate the impact of HIV-1 genetic heterogeneity on performance of nucleic acid testing assays

Clinical Laboratory

Volumn 58, Issue 3-4, 2012, Pages 199-202

  Hackett, John ^a  

^a ABBOTT DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID TESTING ASSAY; PHYLOGENY; SHORT SURVEY; VIRAL GENETICS; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84859878146     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Kuiken C, Foley B, Leitner T, et al, eds. HIV Sequence Compendium 2011. Publisher: Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico. LA-UR-11-11440.
2. Plantier J-C, Leoz M, Dickerson JE, et al. A new human immune-deficiency virus derived from gorillas. Nature Medicine 2009;15:871-2.
3. Hemelaar J, Gouws E, Ghys PD, et al. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25:679-689.
4. Semaille C, Barin F, Cazein F, et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis 2007;196:377-383. (Pubitemid 47093888)
5. Vercauteren J., Wensing AM, van de Vijver DAMC, et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Inf Dis 2009;200:1503-1508.
6. Wheeler WH, Ziebell RA, Zabina H, et al. Prevalence of transmitted drug resistance-associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS 2010;24:1203-1212.
7. Gueudin M, Plantier JC, Lemée V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007;44:500-5. (Pubitemid 46594892)
8. Damond F, Roquebert B, Bénard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol 2007;45:3436-8. (Pubitemid 47585682)
9. Swanson P, de Mendoza C, Joshi J, et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx® HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR version 1.5, Quantiplex HIV RNA version 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 2005;43:3860-8. (Pubitemid 41129673)
10. Nübling CM, Heiden M, Chudy M, et al. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009;49:1850-8.
11. Schmidt M, Korn K, Nübling M.C, et al. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009;49:1836-1844.
12. Tang N, Huang S, Salituro J, et al. Abbott RealTime™ HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M, group O and group N samples. J Virol Methods 2007;146:236-245. (Pubitemid 350026638)
13. Brennan CA, Bodelle P, Coffey R, et al. HIV Global Surveillance: Foundation for retroviral discovery and assay development. J Med Virology 2006;78(S1):S24-9. (Pubitemid 43993461)
14. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998;16:49-53. (Pubitemid 28035948)
15. Livak KJ, Flood SJ, Marmaro J, et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Applic 1995;54:357-362.
16. Gardner SN, Kuczmarski TA, Vitalis EA, et al. Limitations of TaqMan PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E viruses and human immunodeficiency virus. J Clin Microbiol 2003;41:2417-27. (Pubitemid 36712445)
17. Luk K-C, Devare SG, Hackett JJr. Partially double-stranded linear DNA probes: Novel design for sensitive detection of genetically polymorphic targets. J Virol Methods 2007;144:1-11. (Pubitemid 47095030)
18. Huang S, Salituro J, Tang N, et al. Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Research 2007;35:e101.
19. Giachetti C, Linnen JM, Kolk DP, et al. Highly sensitive multiplex assay for detection of human immunodeficiency virus Type 1 and hepatitis C virus RNA. J Clin Microbiol 2002;40:2408-2419. (Pubitemid 34747340)
20. Edelmann A, Kalus U, Oltmann A, et al. Improvement of an ultrasensitive human immunodeficiency virus Type 1 real-time reverse-transcriptase-polymerase chain reaction targeting the long terminal repeat region. Transfusion 2010;50:685-692.
21. Karasi JC, Dziezuk F, Quennery L, et al. High correlation between Roche COBAS Ampliprep/COBAS TaqMan HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B strains. J Clin Virol 2011;52:181-6.
22. Troppan KT, Stelzl E, Violan D, et al. Evaluation of the new Versant HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA. J Clin Virol 2009;46:69-74.